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Abstract
Purpose To evaluate the safety, efficacy, and feasibility of transcatheter arterial embolization (TAE) in the treatment of lower
gastrointestinal bleeding (LGIB).
Methods Study group comprised all patients receiving angiography for LGIB in the Helsinki University Hospital during the
period of 2004–2016. Hospital medical records provided the study data. Rebleeding, complication, andmortality rates (≤ 30 days)
were the primary outcomes. Secondary outcomes included need for blood transfusions, durations of intensive care unit and
hospital admissions, incidence of delayed rebleeding, and long-term complications, as well as overall survival.
Results During the study period, angiography for LGIB was necessary on 123 patients. Out of 123, 55 (45%) underwent
embolization attempts. TAE was technically successful in 53 (96%). Rebleeding occurred in 14 (26%). The complication rate
was 36%, minor complications occurring in 10 (19%) and major in nine (17%). Major complications resulted in bowel resection
in seven (13%). Post embolization ischemia was the most common single complication seen in nine (17%). The mortality rate
was 6%. Survival estimates of 1 and 5 years were 79 and 49%.
Discussion LGIB is a severe physiological insult occurring in patients who are often elderly and moribund. Although major post
embolization complications occur, transcatheter arterial embolization should be the first-line approach over surgery in profuse
LGIB in patients with hemodynamic instability, when colonoscopy fails or is unavailable, or when computerized tomography
angiography detects small intestinal bleeding.
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Introduction
Lower gastrointestinal bleeding (LGIB) refers to intestinal
bleeding arising distal to the ligament of Treitz. It is a com-
mon cause of hospitalization in surgical emergency units
with an incidence of 20–30 per 100,000 and with mortality
reaching 5%.1 Accounting for up to 17–40% of the bleeding
episodes, diverticular disease is the most common etiology.
Other etiologies include colonic vascular ectasia, colitis,
tumors and post polypectomy bleeding, anorectal causes
(e.g., hemorrhoids and varices), and bleeding from the
small bowel (e.g., angioectasia, Meckel’s diverticula, tu-
mors, Crohn’s ileitis).2 Of the bleeding episodes, 80% re-
solve themselves spontaneously, the remaining requiring
interventional management.2 As the first-line approach,
modern guidelines recommend urgent colonoscopy within
24 h,3,4 as it confirms the definitive diagnosis in 74–100%5
and allows simultaneous therapeutic interventions.
Colonoscopy requires bowel prep and sedation as well as
endoscopy facilities and an experienced endoscopist, which
may limit its availability. A readily available method for
localizing the bleeding in most emergency rooms is com-
puterized tomography angiography (CTA). It has the ability
to visualize bleeding when the bleeding rate exceeds 0.3 ml/
min and has a diagnostic yield of 54–79%.6 When CTA is
positive for bleeding, another possible therapeutic approach
is transcatheter arterial embolization (TAE). It is useful es-
pecially in the case of hemodynamic instability, when
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colonoscopy fails, or when the patient would not tolerate
bowel cleansing or other invasive procedures. TAE does
not come without risks, however. It may have serious se-
quelae such as bowel ischemia, angiography-related punc-
ture site complications, and contrast-induced kidney fail-
ure. 6,7
The purpose of this study was to evaluate the safety, effi-
cacy, and feasibility of TAE in the treatment of LGIB with
rebleeding, complication, and mortality rates (≤ 30 days) as
primary outcomes. Secondary outcomes include the need for
blood transfusions, the durations of intensive care and hospital
admissions, the incidence of delayed rebleeding, and long-
term complications, as well as all-cause mortality.
Materials and Methods
Patients
The study comprised all patients ≥ 18 years undergoing angi-
ography and embolization for LGIB in the Helsinki University
Hospital during the period 2004–2016. Interventional codes
for coeliac, mesenteric, and iliac angiographies and emboliza-
tions enabled identifying patients from the hospital picture
archiving and communication system (PACS). Clinical, endo-
scopic, and imaging findings confirmed the diagnosis of
LGIB.
Clinical Data and Definitions
Hospital medical records provided the study data comprising
demographic details, comorbidities, medication, symptoms,
clinical findings, laboratory and imaging results, interven-
tions, complications, and follow-up notes. Statistics Finland
provided the time and cause of death.
Assessing the safety and feasibility of TAE required de-
fining rates for technical success, clinical success,
rebleeding, complications, and mortality. When TAE was
feasible and post embolization angiography showed dis-
continuation of bleeding, TAE was technically successful.
Clinical success implied no rebleeding, major complica-
tions, or mortality within a 30-day follow-up. Rebleeding
and delayed rebleeding referred to recurrence of bleeding
symptoms within 30 days and more than 30 days from TAE.
Reporting complication and mortality rates occurred at
30 days after embolization. The Society of Interventional
Radiology Standards of Practice Committee guidelines en-
abled classifying complications as minor or major.8 Minor
complications do not necessitate reoperations or result in a
significant increase in the level of care. Major complica-
tions require therapeutic interventions and may cause a
prolonged hospital stay, permanent disability, or death.
Statistical Analysis
IBM SPSS version 24 (SPSS Inc., Chicago, IL) facilitated
statistical analysis. Categorical data is expressed as percent-
ages and continuous data as medians (range). The Mann-
Whitney U test allowed the comparison of continuous data.
Univariate binary logistic regression enabled assessing factors
associated with recurrent bleeding. Kaplan-Meier analysis
gave estimates of survival. Two-tailed tests allowed defining
the P values that indicated statistical significance when < 0.05.
Ethical Approval
The Helsinki University Hospital Research Board granted the
study approval. Finnish law allows conducting medical re-
search using hospital records without patient approval. Thus,
obtaining informed patient consent was not necessary.
Initial Evaluation and Management
The Helsinki University Hospital is a tertiary teaching hospital
with a catchment area of 1.6 million people and 24/7 avail-
ability for emergency endoscopies and TAE. Referring pa-
tients with LGIB occurs from primary health care in the
Helsinki area and surrounding hospitals without facilities for
emergency interventions for LGIB.
Initial evaluation and management of bleeding patients
take place at the surgical emergency room. Patients receive
fluid resuscitation and packed red blood cells (RBCs). Other
blood products and medications may be necessary to optimize
the clotting status and hemodynamics. Resuscitation and sta-
bilization occur at the anesthetist-led intensive monitoring fa-
cility of the emergency room, after which admission to the
intensive care unit is often unnecessary. Further monitoring
of hemodynamically stable patients and arrangements for co-
lonoscopy workup occur at the surgical ward. In case of un-
stable hemodynamics and continuous bleeding, patients un-
dergo urgent CTA to localize the bleeding. When CTA is
positive, referring the patient to angiography and embolization
follows. Our institution replaced angiography with CTA in the
diagnostics of LGIB in 2007. Until then, angiography also
served a diagnostic purpose.
Transcatheter Arterial Embolization
The detection of the bleeding site occurred with angiography
by catheterizing the superior mesenteric artery (SMA) and/or
inferior mesenteric artery (IMA) (Fig. 1). If angiography
showed no extravasation from these, catheterizing the internal
iliac artery followed. Selective angiographs with microcatheter
enabled visualizing the exact bleeding arterial branch. When
the bleeding site was visible, embolization of the bleeding ar-
tery followed as distal as possible; microcoils, gelatine, and
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particles being the methods used. Provocation of the bleeding
did not occur. When angiography remained negative despite
active bleeding in CTA or endoscopy, empirical embolization
of the suspected bleeding artery took place in a few complicated
cases where laparotomy would have been unfavorable.
Results
During 2004–2016, LGIB necessitated angiography on
123 patients (Fig. 2). Missing follow-up data lead to the
exclusion of two patients. Out of the remaining 121, 71
(59%) had negative and 50 (41%) positive angiographies.
Out of 121, 55 patients—8 with negative and 47 with pos-
itive angiographies—underwent an embolization attempt.
The procedure was technically successful in 53 (96%) pa-
tients, 37 male and 16 female. Table 1 summarizes their
baseline characteristics.
Angiography and Embolization Details
Angiography localized the bleeding in the jejunum or ileum
in 12 (23%), caecum or right hemicolon in eight (15%),
transverse colon in five (10%), left hemicolon or sigmoid
in 14 (26%), and rectum in 14 (26%). The bleeding origi-
nated from the branches of SMA and IMA in 47 and 45% of
bleeding events, internal iliac artery explaining the remain-
ing 8% (Table 2). The median time from hospital admission
to angiography and embolization was 9 h (0–330). Coils
were the most common embolization method used, either
alone (62%) or combined with particles (11%) or gelatine
(6%) (Table 2). Periprocedural complications occurred dur-
ing seven (13%) embolizations (Table 2). All of these
remained clinically irrelevant. After adopting CTA in the
diagnostics of LGIB, embolization rate after angiography
increased (27 vs. 64%, P = 0.000).
Fig. 1 An 81-year-old man




extravasation and diverticulosis in
descending colon (white arrows,
top left and right). Immediate
angiography took place. Contrast
extravasation from the inferior
mesenteric artery (black arrow,
bottom left) was successfully
controlled with coils (black arrow,
bottom right). Severe post
operative abdominal pain
occurred. Two days after
embolization sigmoidoscopy
showed transmural ischemia in
left hemicolon, necessitating left
hemicolectomy
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Embolization Success and Failure
Embolization overall clinical success was 60%. Recurrent
bleeding occurred in 14 (26%), out of which seven (50%)
required reintervention, six (43%) experienced spontaneous
resolution, and one (7%) died (Fig. 3). The severity of bleed-
ing did not differ between the groups with spontaneous reso-
lution and reintervention (median requirement for units of
packed RBCs: 15 (11–58) vs. 18 (6–39), P = 0.486). Odds
for recurrent bleeding were higher with the increasing amount
of red blood cells (RBCs) administered before the salvage
(P = 0.032) and with bleeding originating from the branches
of SMA (P = 0.041) (Table 4). The result for SMA was not
significant with crosstabulation, however (P = 0.06, Fisher’s
exact test). Sex, age, ASA score, anticoagulant therapy, hemo-
globin level at presentation, presence of hemodynamic shock
or coagulopathy, time to embolization, bleeding site, or under-
lying etiology were not associated with recurrent bleeding
(P > 0.05). Rebleeding occurred within a median of 2 days
(0–18) of the embolization. Two patients experienced delayed
rebleeding: one 88 and the other 204 days after the procedure.
After the first bleeding episode, the first patient underwent
negative colonoscopy and the second negative gastroscopy
and colonoscopy. Further examinations took place for both
only after the second bleeding episode. The first received a
repeated colonoscopy and polypectomy for rectal polyp that
was most likely missed during the first endoscopy. The second
underwent magnetic resonance enterography (MRE) showing
an intestinal tumor. Ileal resection followed with the diagnosis
of a malignant gastrointestinal stromal tumor (GIST).
Complications
Complication rate (≤ 30 days) was 36%; 19 patients
experiencing post embolization problems (Table 3). Major
complications occurred in nine (17%). Surgery was necessary
during the same hospital admission on six—due to ischemia in
five (9%) and for a suspected catheter-induced mechanical
bowel perforation in one (2%) (pathology report showed in-
tramural hematoma and perforation but no ischemia close to
the coils). Non-surgical management was initially sufficient in
two: One patient with radiation proctitis received endoscopic
argon coagulation for recurrent bleeding after TAE. Post em-
bolization ischemic colitis, sepsis, and endocarditis devel-
oped, necessitating medical treatment. The other recovered
from ischemic colitis but required surgery for iatrogenic colon
perforation after a balloon dilatation of the ischemic stricture
2 months later. One patient with end-stage endometrial cancer
Fig. 2 Flow chart showing the treatment path of the 123 patients undergoing angiography for lower gastrointestinal bleeding (LGIB) in the Helsinki
University Hospital during the period 2004–2016. TAE transcatheter arterial embolization
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died of post embolization rectal ischemia. Minor complica-
tions occurred in 10 (19%) and comprised self-limiting ische-
mia, pneumonia, puncture site hematoma, and post emboliza-
tion abdominal pain. They did not require further interven-
tions. The most prevalent single complication was computer-
ized tomography- or endoscopy-verified ischemia occurring
in nine (17%). Surgery was necessary on six, two recovered
spontaneously without any permanent sequelae, and one died.
Crosstabulation or univariate logistic regression did not reveal
any associations between the incidence of ischemia and the
bleeding site or the embolized artery (P < 005). Contrast-
induced acute kidney insufficiency did not occur.
Mortality
The mortality rate (≤ 30 days) was 6%; three patients dying
within 30 days of TAE (Table 4). One patient who suffered a
warfarin overdose (INR > 9) died of profuse bleeding from the
transverse colon. One died of exacerbation of underlyingmed-
ical conditions after controlling of the bleeding. The patient
with end-stage endometrial cancer died of post embolization
ischemia. After excluding the three patients dying within
30 days of the embolization, the median duration of the
follow-up was 31 months (3–174). By the time of data retriev-
al, 26 (49%) patients had died; neurological disorders (27%),
malignancies (19%), and cardiovascular diseases (15%) being
Table 2 Angiography and embolization details
n = 53
Indication for embolization, n (%)
Active bleeding 45 (85)
Empirical 8 (15)
Time to embolizationa (h) 9 (0–330)




Right colic artery 4
Medial colic artery 4
Lienal flexure branches 1
IMA 24 (45)
Left colic artery 13
Sigmoid arteries 2
Superior rectal artery 9
Internal iliac artery 4 (8)




Coils and particles 6 (11)
Coils and gelatine 3 (6)
Particles and gelatine 2 (4)




Perioperative ischemic pain 2
SMA superior mesenteric artery, IMA inferior mesenteric artery
aMedian (range)
Table 1 Patient baseline characteristics
n= 53
Agea, (years) 72 (30–95)
Sex, n (%)
Male/female 37 (70)/16 (30)






Risk factors, n (%)






Abdominal pain 6 (11)
Bleeding onset, n (%)
Home/health-care facility 43 (81)/10 (19)
Clinical findings on admission
Systolic blood pressurea, (mmHg) 111 (66–178)
Heart rate, (BPM) 82 (40–124)
Unstable hemodynamicsb, n (%) 24 (45)
Noradrenaline infusion, n (%) 15 (27)
Hemoglobina (g/l) 84 (33–147)
Platelet counta (E9/l) 179 (59–473)
Thromboplastin timea (TT%) 63 (1–121)
Coagulopathyc, n (%) 16 (30)
Pre-embolization investigations, n (%)
Gastroscopy 19 (36)
Colonoscopy or sigmoidoscopy 10 (19)
CTA 34 (64)
Positive/negative 30/4
ASA American Society of Anesthesiology, NSAID non-steroidal anti-in-
flammatory drug, BPM beats per minute, TT thromboplastin time, CTA
computerized tomography angiography
aMedian (range)
b Systolic blood pressure < 100 mmHg and/or heart rate > 100 beats per
minute
c Thrombocyte count < 50 E9/L and/or TT%< 50
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the most common causes of death. Survival estimates of 1 and
5 years were 79% (asymptotic 95% CI 67.7–90.5) and 49%
(asymptotic 95% CI 32.8–64.6).
Empirical Embolization
Out of 53, 8 underwent empirical embolization after negative
angiography. A positive CTA beforehand guided the
embolization in five and metallic clips inserted during endos-
copy in one. With the last two, the indication for empirical
embolization was clinically diagnosed as bleeding from a rec-
tal tumor: the first had newly diagnosed rectal carcinoma with
definitive surgical treatment planned after neoadjuvant che-
moradiation, and the other had inoperable metastatic rectal
cancer with a rectovesical fistula. After empirical TAE, recur-
rent bleeding occurred in three (38%), resolving
Fig. 3 Flow chart showing the results (≤ 30 days) of transcatheter arterial
embolization (TAE) in the study group of 55 patients undergoing
embolization attempt for lower gastrointestinal bleeding (LGIB) in the
Helsinki University Hospital during 2004–2016. Technical success:
immediate cessation of bleeding after TAE, clinical success: no
rebleeding, major complications or mortality within 30 days of TAE,
rebleeding: recurrence of bleeding symptoms within 30 days of TAE,
major complication: complication that requires therapeutic intervention
and may result in prolonged hospital stay, permanent disability, or death
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spontaneously in all of them. The incidence of recurrent bleed-
ing was not significantly higher after empirical embolization
than after embolization for active bleeding (P = 0.422). Major
complications occurred in 2 (25%), both leading to bowel
resection. Patients with empirical embolization received a me-
dian of 13 (4–27) units of packed RBCs.
Etiology of Bleeding
The most prevalent etiology of LGIB was diverticular disease,
accounting for 39% of the bleeding episodes (Table 3).
Hemodynamic instability often resulted in embolization with-
out preceding diagnostic workup for the etiology of bleeding.
Additional examinations took place at outpatient clinics after
the initial hospital admission with a median delay of 9 weeks
(1–38). Confirming the etiology occurred with pre or post
embolization colonoscopy in 32 (60%), capsule endoscopy
in five (9%), and double-balloon enteroscopy (DBE) in one
(2%). CT colonography and MRE were useful in one (2%).
Surgical bowel resection was sufficient in seven (13%). Out of
53, 11 (21%) did not undergo further diagnostics: CTA find-
ings were convincing enough in five, three were of advanced
age, and three died within 30 days of TAE. No definitive
diagnosis could be established in 10 (19%), although five of
these received endoscopic examinations after TAE (colonos-
copy, capsule endoscopy) (Table 3). The remaining five only
underwent pre-embolization CTA or angiography but no en-
doscopic examinations (two for reasons not clear, two died
within 30 days of TAE, and one was of advanced age).
Discussion
The current study shows a rebleeding rate (≤ 30 days) of 26%
and mortality rate (≤ 30 days) of 6%. The findings are consis-
tent with recently published studies reporting rebleeding rates
of 7.7–26% and mortality rates of 0–31.5% (Table 5). 9
–18
Ischemic complications were prevalent; the aforemen-
tioned studies report ischemia in 3–13% while in the
Table 4 Univariate logistic regression modeling for predictors of
recurrent bleeding
OR 95% CI Pd
Sex (m/f) 3.36 0.66–17.21 0.146
Age (> 70 years/< 70 years) 0.86 0.25–2.91 0.805
ASA scorea
ASA3/ASA1 + 2 5.79 0.65–51.51 0.115
ASA4 + 5/ASA1 + 2 3.67 0.32–41.59 0.294
Anticoagulant therapy (year/n) 1.93 0.52–7.24 0.329
Hemodynamic shockb (year/n) 0.59 0.17–2.06 0.404
Coagulopathyc (year/n) 1.41 0.39–5.17 0.600
Hb (< 80 g/l/> 80 g/l) 1.44 0.42–4.90 0.562
Units of RBCs before salvage 1.12 1.01–1.24 0.032
Time to embolizationd (h) 0.99 0.99–1.01 0.532
Etiology of bleeding NS
Bleeding site NS
Culprit vessel SMA 4.00 1.06–15.08 0.041
ASA American Society of Anesthesiology, RBC red blood cell, SMA
superior mesenteric artery, NS non-significant
a ASA1 combined with 2 and ASA4 combined with 5 due to small num-
ber of patients
b Systolic blood pressure < 100 mmHg and/or heart rate > 100 beats per
minute
c Thrombocyte count < 50 E9/L and/or thromboplastin time < 50 (TT%)
d Time from hospital admission to embolization (h)
e Univariate binary logistic regression, significant at P < 0.05
Table 3 Results
n = 53
Recurrent bleeding, n (%) 14 (26)
Mortality rate, n (%) 3 (6)
Complication rate, n (%) 19 (36)
Minor, n (%) 10 (19)
Major, n (%) 9 (17)
Need for blood transfusions (units of RBCs)a 12 (2–58)
≤ 10 units of RBCs, n (%) 23 (43)
11–20 units of RBCs, n (%) 20 (38)
> 20 units of RBCs, n (%) 6 (11)
Missing data 4 (8)
Duration of ICU treatment, (day)a 0 (0–6)
Duration of hospital admission, (day)a 7 (1–91)
≤ 7 days, n (%) 27 (51)
8–14 days, n (%) 13 (25)
14–21 days, n (%) 9 (17)
> 21 days, n (%) 4 (7)
Follow-up data > 30 days
Delayed rebleeding, n (%) 2 (4)
Ischemic strictures, n (%) 1 (2)
Duration of follow-up, (months)a 31 (3–174)b
Etiology of bleeding, n (%)
Diverticular disease 21 (39)
Malignant tumor 6 (11)
Post polypectomy 7 (13)
Colitis 4 (8)
Radiation proctitis 2 (4)
Angioectasia 1 (2)
GVHD 1 (2)
Benign tumor 1 (2)
No definitive diagnosis 10 (19)
RBC red blood cell, ICU intensive care unit, GVHD graft versus host
disease
aMedian (range)
b Three patients dying ≤ 30 days after embolization excluded
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present study it occurred in 17% and necessitated surgery in
11%. The actual incidence of ischemia could be even
higher, as 5 (9%) patients experienced spontaneously re-
solving post embolization abdominal pain but did not un-
dergo any endoscopic or CT examinations. In current study,
the patients suffering surgery-requiring or lethal ischemia
may have received embolization less selectively than what
is optimal. Superselective embolization should cover only
the extravasating vasa recta artery or arteries. A retrospec-
tive review of the angiograms of patients with ischemia
shows parallel coils in two or three vasa recta vessels and
additional coils even in the level of the marginal artery in
two patients. The findings emphasize the importance of as
superselective approach as possible to minimize the risk of
ischemia.
CTA directs clinical decision-making between colonos-
copy, TAE, and surgery, and is the diagnostic method of
choice for patients with active LGIB and hemodynamic
instability. Colonoscopy has a diagnostic yield of 74 to
100%5 and the potential to eliminate embolization-related
risks. It is the recommended first-line intervention in the
diagnosis and management of LGIB for hemodynamically
stable patients. Colonoscopy seems a rational approach also
in post operative bleeding from the colon. Anastomotic
bleeding or post polypectomy bleeding should not be diffi-
cult to locate. Moreover, colonoscopy does not compromise
circulation in the area of anastomosis or thin polypectomy
sites. Colonoscopy after proper bowel cleansing should be
the first-line intervention for all hemodynamically stable
patients with LGIB unless the preceding CTA detects
bleeding in the small intestine. The number of urgent colo-
noscopies (≤ 24 h) in our institution has been low mostly
due to the limited availability of endoscopic services out-
side regular working hours. It is noteworthy that despite
current treatment algorithms for LGIB, only 19% of pa-
tients received colonoscopy and 36% gastroscopy before
embolization in the current study. Angiography localized
the bleeding in the rectum in 26% and at least these, as most
of the patients embolized for post polypectomy bleeding,
should have rather been diagnosed and managed with en-
doscopy instead of predisposing the patients to the risks of
angiography and embolization.
Bleeding in the small intestine comprises less than 15% of
all LGIB.1,6 In the selected population of the present study,
however, small intestinal sources explained the bleeding in
23%. In their similar cohort of patients, Gillespie et al. report-
ed bleeding from the small intestine in 34%.13 With this in
mind, surgeons dealing with profuse LGIB should avoid
performing blind subtotal colectomies and invest every effort
in localizing the bleeding. A reasonable first-line approach in
small intestinal bleeding is angiography and embolization.
Coil embolization should be the preferred method, as the pal-
pable coils can guide surgical resection if bleeding recurs.
Coils are also easier to position and control than particles with

















Nykänen et al. 2018 2004–2016 53 96 26 17 6 79 49
Bua-ngam et al. 2017 2007–2015 39 92 26 13 31.5b
Hur et al. 2014 2006–2013 112 96.4 17.4 4.6 25b
Teng et al. 2013 1997–2009 26 84.6 7.7 7.7a 19.2 58.2 43.1
Huang et al. 2011 2006–2008 27 100 14.8 0 44
Gillespie et al. 2010 1998–2008 38 93 24 0 2.6
Maleux et al. 2009 1997–2008 39 100 15 10a 15 70.6 50.8
Frodsham et al. 2009 2005–2009 14 100 14 0 7
Koh et al. 2009 2000–2006 68 100 8.8 5.9 0
Tan et al. 2008 2000–2007 32 97 22 3a 9
Lipof et al. 2008 1999–2005 75 97 16 7 11
TAE transcatheter arterial embolization
1 Immediate cessation of bleeding after TAE
2Bleeding recurrence within 30 days of TAE
3 Ischemic complications within 30 days of TAE
4Mortality within 30 days of TAE
a Ischemic complications requiring bowel resection
b In-hospital mortality after TAE
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a smaller risk for non-target embolization and consequent is-
chemia. After controlling the bleeding, further diagnostics for
the underlying etiology with capsule endoscopy or MRE are
of great importance. In the present study, a small intestinal
tumor was detectable in four out of 12 (33%) patients bleeding
from the small bowel. The pathology report showed GIST in
two and a neuroendocrine tumor in one. Polypectomy for
Peutz-Jeghers polyposis resulted in bleeding after DBE in
the remaining one.
Previous studies on the safety and efficacy of TAE include
patients embolized after positive angiography. Intermittent
bleeding may render angiography negative even after positive
CTA. Due to the risk of post embolization ischemia, empirical
embolization for LGIB after a negative angiogram is generally
discouraged, and thus not a routine practice. The validity of
this paradigm in the era of CTA and evolving imaging tech-
niques is increasingly questioned, however. Gupton described
a case of successful empirical embolization, where the preced-
ing positive CTA guided the superselective embolization of
the right inferior rectal artery.19 The current study included
eight empirically embolized patients with rebleeding, compli-
cation (major complications), and mortality rates of 38, 25,
and 0%, respectively. Rather than being routine practice, most
of these patients received empirical embolization as the last
resort in complicated situations where clinicians wanted to
avoid laparotomy. Embolization occurred after visualizing
the bleeding artery in CTA or endoscopy. In our experience,
however, embolizing the true culprit artery in negative angi-
ography according to a positive CTA is uncertain and difficult.
Adding the considerable risk of post embolization ischemia,
we do not recommend empirical embolizations in LGIB with
current imaging methods and embolization techniques.
The study is limited due to its single-center setting, retro-
spective nature, and small study population that may render
true statistical associations undetected. The strength of the
study lies in its long follow-up, enabling assessing the patency
of the bleeding control after embolization, incidence of ische-
mic bowel strictures, and long-term survival.
As a conclusion, TAE has a well-established role in the
treatment of LGIB. Services from interventional radiologists
should be available in hospitals attending for abdominal emer-
gencies. Embolization benefits only a small proportion of pa-
tients with LGIB, however. The majority of the bleeding ep-
isodes resolve themselves spontaneously. Even during the era
of routine preceding CTA, the current study proved emboliza-
tion feasible after angiography in only 64%. Although major
post embolization complications were prevalent, LGIB per se
is a severe physiological insult occurring in patients who are
often elderly and moribund. Transcatheter arterial emboliza-
tion should be the first-line approach over surgery in profuse
LGIB for patients with hemodynamic instability, when colo-
noscopy fails or is unavailable, or when computerized tomog-
raphy angiography detects bleeding in the small intestine. All
other patients should undergo urgent colonoscopy after proper
bowel cleansing. To avoid predisposing patients with LGIB to
unnecessary complications in TAE or surgery, emergency en-
doscopic services should be of high quality and available at
short notice.
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